08.24.2021 - By JAMA Network
FDA’s Approval of New Alzheimer Drug Raises Many Questions; Überantibodies From Recovered COVID-19 Patients Could Spur New Therapeutics and Vaccines; Detecting Kids’ Broken Hearts—Cardiac Screening Advised During Well-Child Visits Related Content: Recently Approved Alzheimer Drug Raises Questions That Might Never Be Answered Überantibodies From Recovered COVID-19 Patients Could Spur New Therapeutics and Vaccines Detecting Kids’ Broken Hearts—Cardiac Screening Advised During Well-Child Visits